BeyondSpring Inc. Profile Avatar - Palmy Investing

BeyondSpring Inc.

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has co…

Biotechnology
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

BeyondSpring Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

BeyondSpring Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of BeyondSpring Inc..

End of BYSI's Analysis
CIK: 1677940 CUSIP: G10830100 ISIN: KYG108301006 LEI: - UEI: -
Secondary Listings
BYSI has no secondary listings inside our databases.